XML 72 R27.htm IDEA: XBRL DOCUMENT
v3.24.0.1

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Revenue from Contract with Customer [Abstract] |
Schedule of Changes in Contract Assets and Contract Liabilities | The following table summarized the changes in the contract asset and liability balances for the year ended December 31, 2023:
Dollars in thousands | Total
Contract Asset |
Contract asset, January 1, 2023 | $ | 10,122 |
Transferred to trade receivable from contract asset included in beginning of the year contract asset | (7,743) |
Written off from beginning of the year contract asset due to Boston recall | (2,379) |
Contract asset, net of transferred to trade receivables on contracts during the period | 9,233 |
Contract asset, December 31, 2023 | $ | 9,233 |
Contract Liability |
Contract liability, January 1, 2023 | $ | 16,127 |
Recognition of revenue included in beginning of year contract liability | (6,834) |
Contract liability, net of revenue recognized on contracts during the period | 6,951 |
Foreign currency translation | 8 |
Contract liability, December 31, 2023 | $ | 16,252 |
Schedule of Disaggregation of Revenue | The following table presents revenues disaggregated by the major sources of revenues for years-ended December 31, 2023, 2022 and 2021 (dollar amounts in thousands):
|  |  |  | Year Ended December 31, 2023 | Year Ended December 31, 2022 | Year Ended December 31, 2021
Neurosurgery |  |  |  | $ | 818,101 |  | $ | 794,017 |  | $ | 802,959 |
Instruments |  |  |  | 240,892 |  | 225,547 |  | 222,273 |
Total Codman Specialty Surgical |  |  |  | 1,058,993 |  | 1,019,564 |  | 1,025,232 |
Wound Reconstruction and Care(1)(2) |  |  |  | 373,986 |  | 406,689 |  | 392,463 |
Private Label |  |  |  | 108,594 |  | 131,413 |  | 124,753 |
Total Tissue Technologies |  |  |  | 482,580 |  | 538,102 |  | 517,216 |
Total revenue |  |  |  | $ | 1,541,573 |  | $ | 1,557,666 |  | $ | 1,542,448 |
(1) See Note 4. Acquisitions and Divestitures, for details around the ACell and SIA acquisitions. (2) On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note 4, Acquisitions and Divestitures

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration